The Economic Argument for Better Services for FND

We're spending a huge amount of money on FND, whether people want to or not, they're spending it. We know that the cost-effectiveness is a bit harder. Do you think we can use this data to argue for better services for FND? Or do we need the economic arguments to do better? I think the data from the review makes a compelling argument at one level that we should be investing in clinical and academic pathways for these patients.